SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-12G/A - Registration of securities [Section 12(g)]: [Amend]
SEC Accession No. 0001104659-13-086305
Filing Date
2013-11-21
Accepted
2013-11-21 14:51:47
Documents
5

Document Format Files

Seq Description Document Type Size
1 10-12G/A a13-22603_21012ga.htm 10-12G/A 48264
2 EX-10.4 a13-22603_2ex10d4.htm EX-10.4 438396
3 EX-10.5 a13-22603_2ex10d5.htm EX-10.5 148133
4 EX-99.1 a13-22603_2ex99d1.htm EX-99.1 1288114
5 filename5.htm CORRESP 21927
  Complete submission text file 0001104659-13-086305.txt   1945896
Mailing Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170 212-297-0020
ContraVir Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-12G/A | Act: 34 | File No.: 000-55020 | Film No.: 131235142
SIC: 2834 Pharmaceutical Preparations